A polymorphism of the methylenetetrahydrofolate reductase and methionine synthase gene in CAD patients: Association with plasma folate, vitamin B12 and homocysteine

Nutrition Research

Volumn 22, Issue 9, 2002, Pages 965-976

  Jang, Yangsoo ^a   Park, Hyun Young ^a   Lee, Jong Ho ^b   Ryu, Ha Jung ^b   Kim, Ji Young ^b   Kim, Oh Yoen ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Coronary artery disease; Folate; Homocysteine; Methionine synthase; Methylenetetrahydrofolate reductase; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0036730126     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(02)00416-5     Document Type: Article

References (37)

1. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
2. Homocysteine and cardiovascular disease: Cause or effect?
3. Plasma homocysteine levels and mortality in patients with coronary artery disease
4. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
5. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
6. Hyperhomocyst(e)inemia. A common, and easily reversible risk factor for occlusive atherosclerosis
7. The effect of diet on plasma homocysteine concentrations in healthy male subjects
8. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: The Hordaland homocystein study
9. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
10. Polymorphism of the methioine synthase gene: Association with homocysteine metabolism and late-onset vascular disease in the Japanese population
11. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease
12. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction
13. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
14. Human methionine synthase: cDNA cloning, and identification of mutations in patients of the cb/G complementation group of folate/cobalamin disorders
15. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine
16. Hyperhomocysteinemia in chronic alcoholism: Relations to folic acid and vitamins B(6) and B(12) status
17. Genetic causes of mild hyperhomocystein-emia in patients with premature occlusive coronary artery diseases
18. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
19. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation
20. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
21. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
22. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: A case-control study
23. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: Evidence for an important genetic-environmental interaction
24. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study
25. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD)
26. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction
27. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction
28. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease
29. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease
30. The 677C→T mutation in the methylenetetrahydrofolate reductase gene: Associations with plasma total homocysteine levels, and risk of coronary atherosclerotic disease
31. A common mutation in the methylenetetrahydrofolate reductase gene, and risk of coronary heart disease: Results among U.S. men
32. Methylenetetrahydrofolate reductase gene and coronary artery disease
33. The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease
34. Methylenetetrahydrofolate reductase genotypes, and early-onset coronary artery disease
35. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease
36. 12, homocyst(e)ine, and colorectal cancer risk
37. The controversy over homocysteine and cardiovascular risk